Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

48843

	registered interest
	date	28/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department has taken to address patient concerns regarding the use of transvaginal mesh implants.
	tabling member constituency	Livingston
	tabling member printed	Graeme Morrice
	uin	196957
	answer	answer is ministerial correction date of answer 07/05/2014 answer text <p>Work to improve outcomes for women undergoing procedures involving urethral tape and vaginal mesh is currently under way and is being led by NHS England. The Department is involved in this work alongside the Medicines and Healthcare products Regulatory Agency (MHRA), the specialist societies (The British Society of Urogynaecology (BSUG) and The British Association of Urological Surgeons (BAUS)) and the Royal College of Obstetricians and Gynaecologists.</p><p> </p><p>In addition, Professor Sir Bruce Keogh, Medical Director, NHS England has written to the National Health Service to highlight the need to ensure that</p><p> </p><p>- National Institute for Health and Care Excellence guidance for these procedures is followed;</p><p>- consent procedures are standardised so that they comply with up to date evidence and follow BSUG and BAUS guidance;</p><p>- all pelvic organ prolapse procedures and all incontinence operations, but particularly those involving mesh, are recorded on a recognised database e.g. the BSUG or BAUS surgical databases;</p><p>- all adverse events are reported to MHRA; and</p><p>- surgery for removal of tapes or prolapse mesh or repeat surgery for incontinence or prolapse is performed in units which can demonstrate relevant specialist care.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 07/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	4012 label Biography information for Graeme Morrice

48547

	registered interest
	date	25/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many (a) meetings, (b) items of written correspondence, (c) phone calls, (d) consultation responses, (e) tenders and (f) other individual communications and contacts his Department has had with (i) Johnson & Johnson, (ii) Ethicon and (iii) BARD.
	tabling member constituency	Livingston
	tabling member printed	Graeme Morrice
	uin	196778
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>Within the last 12 months, the Department has had regular communication with a number of pharmaceutical, device and diagnostic manufacturers, on a wide range of topics. However, the information requested could only be provided at disproportionate cost.</p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 06/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	4012 label Biography information for Graeme Morrice

48276

	registered interest
	date	10/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to the Answer of 24 March 2014, Official Report, column 120W, on haemolytic uraemic syndrome, what discussions NHS England has had with the National Institute for Health and Care Excellence (NICE) since 1 January 2014 on NICE's appraisal of eculizumab; and if he will make a statement.
	tabling member constituency	Eddisbury
	tabling member printed	Mr Stephen O'Brien
	uin	196426
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>We understand that NHS England was formally consulted on the scope of the National Institute for Health and Care Excellence's (NICE) evaluation of eculizumab for atypical haemolytic uraemic syndrome. NHS England was also consulted on the evaluation consultation document, which was published on 27 February.</p><p> </p><p>Following the publication of NICE's draft guidance on eculizumab, NICE sought further advice from NHS England on what considerations relating to the management of its specialised commissioning budget it considers should be taken into account in formulating a recommendation. The response from NHS England will be considered by NICE at the next meeting of the evaluation committee.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 06/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	427 label Biography information for Mr Stephen O'Brien

48281

	registered interest
	date	10/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will discuss with the National Institute for Health and Care Excellence (NICE) ensuring that assessments of treatments by NICE conducted through (a) normal technology appraisals and (b) highly specialised technology appraisals is consistent in its (i) engagement with stakeholders and (ii) wider methodological approaches.
	tabling member constituency	Eddisbury
	tabling member printed	Mr Stephen O'Brien
	uin	196428
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>We have no plans to do so. As an independent body, the National Institute for Health and Care Excellence is responsible for developing its methods and processes and applying them consistently.</p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 06/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	427 label Biography information for Mr Stephen O'Brien

49188

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment his Department has made of potential geographical variations in the handling of individual funding requests for the prescription of Duodopa to patients with Parkinson's disease.
	tabling member constituency	Ealing, Southall
	tabling member printed	Mr Virendra Sharma
	uin	197327
	answer	answer is ministerial correction date of answer 08/05/2014 answer text <p>We have made no such assessments.</p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 197328 question first answered 08/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	1604 label Biography information for Mr Virendra Sharma

49189

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment his Department has made of time spent by clinicians on producing and administering individual funding requests for the prescription of Duodopa to patients with Parkinson's disease.
	tabling member constituency	Ealing, Southall
	tabling member printed	Mr Virendra Sharma
	uin	197328
	answer	answer is ministerial correction date of answer 08/05/2014 answer text <p>We have made no such assessments.</p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 197327 question first answered 08/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	1604 label Biography information for Mr Virendra Sharma

49807

	registered interest
	date	06/05/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent discussions he has had with the Minister for Health in Northern Ireland on the establishment of a cancer drugs fund; and if he will make a statement.
	tabling member constituency	South Down
	tabling member printed	Ms Margaret Ritchie
	uin	197834
	answer	answer is ministerial correction date of answer 13/05/2014 answer text <p>We have had no such discussions.</p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 13/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

48583

	registered interest
	date	25/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what estimate he has made of the number of people diagnosed with post-traumatic stress disorder in the last five years.
	tabling member constituency	Liverpool, Wavertree
	tabling member printed	Luciana Berger
	uin	196484
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>We do not collect the information requested centrally. However, the survey, Adult Psychiatric Morbidity in England – 2007 found that overall, 3.0% of adults screened positive for current post-traumatic stress disorder (PTSD).</p><p> </p><p>The King's Centre for Military Health Research recently published ‘The mental health of the UK Armed Forces in the 21st century: resilience in the face of adversity' which also recognises that PTSD rates in the United Kingdom general population are approximately 3%.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 06/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	4036 label Biography information for Luciana Berger

48832

	registered interest
	date	28/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, from what date the statutory duty of candour will be implemented; and if he will make a statement.
	tabling member constituency	Chatham and Aylesford
	tabling member printed	Tracey Crouch
	uin	196897
	answer	answer is ministerial correction date of answer 07/05/2014 answer text <p>We announced, in ‘Hard Truths' the Government's response to the Mid Staffordshire public inquiry, that “subject to Parliamentary approval from 2014 every organisation registered with the Care Quality Commission will be expected to meet a new duty of candour”.</p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 07/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	3950 label Biography information for Dame Tracey Crouch

50620

	registered interest
	date	12/05/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he is taking to improve the early intervention in and treatment for rheumatoid arthritis.
	tabling member constituency	Fylde
	tabling member printed	Mark Menzies
	uin	198399
	answer	answer is ministerial correction date of answer 14/05/2014 answer text <p>Through the Mandate we have asked NHS England to make measurable progress towards making our health service among the best in Europe at supporting people with ongoing health problems, such as rheumatoid arthritis, to live healthily and independently, with much better control over the care they receive.</p><p> </p><p>In 2009, the National Institute for Health and Care Excellence (NICE) published clinical guidance on the management of rheumatoid arthritis (RA) in adults, which set outs best practice on the diagnosis, care, treatment and support of patients. The guidance makes clear the importance of early diagnosis and is explicit that</p><p>suspected cases should be referred as an urgent priority for specialist assessment and that early initiation of treatment can prevent irreversible damage to joints.</p><p> </p><p>In addition to this, information on the diagnosis and treatment of RA can also be accessed via the NICE Clinical Knowledge summaries website at:</p><p> </p><p>http://cks.nice.org.uk/rheumatoid-arthritis</p><p> </p><p>More general information for the public can be found on the NHS Choices website at:</p><p> </p><p>www.nhs.uk/conditions/rheumatoid-arthritis</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 14/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	3998 label Biography information for Mark Menzies